IT7951122A0 - Preparato farmaceutico contenente un agente polimerico per rilasciare acido 5-amminosalicilico e suoi sali nel tratto gastrointestinale,eprocedimento di preparazione - Google Patents

Preparato farmaceutico contenente un agente polimerico per rilasciare acido 5-amminosalicilico e suoi sali nel tratto gastrointestinale,eprocedimento di preparazione

Info

Publication number
IT7951122A0
IT7951122A0 IT7951122A IT5112279A IT7951122A0 IT 7951122 A0 IT7951122 A0 IT 7951122A0 IT 7951122 A IT7951122 A IT 7951122A IT 5112279 A IT5112279 A IT 5112279A IT 7951122 A0 IT7951122 A0 IT 7951122A0
Authority
IT
Italy
Prior art keywords
salts
release
gastrointestinal tract
aminosalicylic acid
polymer agent
Prior art date
Application number
IT7951122A
Other languages
English (en)
Other versions
IT1162426B (it
Inventor
Thomas M Parkinson
Joseph P Brown
Robert E Wingard
Original Assignee
Dynapol Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/971,609 external-priority patent/US4190716A/en
Application filed by Dynapol Corp filed Critical Dynapol Corp
Publication of IT7951122A0 publication Critical patent/IT7951122A0/it
Application granted granted Critical
Publication of IT1162426B publication Critical patent/IT1162426B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G85/00—General processes for preparing compounds provided for in this subclass
    • C08G85/004—Modification of polymers by chemical after-treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/34—Introducing sulfur atoms or sulfur-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48—Polymers modified by chemical after-treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT51122/79A 1978-12-20 1979-12-18 Preparato farmaceutico contenente un agente polimerico per rilasciare acido 5-amminosalicilico e suoi sali nel tratto gastrointestinale,e procedimento di preparazione IT1162426B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/971,609 US4190716A (en) 1978-12-20 1978-12-20 Polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
US06/095,411 US4298595A (en) 1978-12-20 1979-11-29 Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract

Publications (2)

Publication Number Publication Date
IT7951122A0 true IT7951122A0 (it) 1979-12-18
IT1162426B IT1162426B (it) 1987-04-01

Family

ID=26790195

Family Applications (1)

Application Number Title Priority Date Filing Date
IT51122/79A IT1162426B (it) 1978-12-20 1979-12-18 Preparato farmaceutico contenente un agente polimerico per rilasciare acido 5-amminosalicilico e suoi sali nel tratto gastrointestinale,e procedimento di preparazione

Country Status (16)

Country Link
US (1) US4298595A (it)
EP (1) EP0013000B1 (it)
AT (1) AT366068B (it)
AU (1) AU535100B2 (it)
CA (1) CA1130281A (it)
DE (1) DE2966737D1 (it)
DK (1) DK541879A (it)
ES (1) ES8101630A1 (it)
FI (1) FI793991A (it)
GR (1) GR68718B (it)
IL (1) IL58969A (it)
IT (1) IT1162426B (it)
MC (1) MC1302A1 (it)
NO (1) NO794171L (it)
NZ (1) NZ192458A (it)
PT (1) PT70615A (it)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
WO1984004041A1 (en) * 1983-04-14 1984-10-25 Univ California Colon-specific drug delivery system
GB8401166D0 (en) * 1984-01-17 1984-02-22 Bevaloid Ltd Labelled polymer compositions
US5032572A (en) * 1984-07-18 1991-07-16 Medical College Of Ohio Polymers containing cross-linked azo bonds, which polymers are useful for releasing therapeutic agents into the lower gastrointestinal tract
US4663308A (en) * 1984-07-18 1987-05-05 Medical College Of Ohio Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract
US5484605A (en) * 1988-11-25 1996-01-16 Henning Berlin Gmbh Chemie-Und Pharmawerk Agent for treating chronically inflammatory intestinal diseases
BE1003677A3 (nl) * 1990-01-29 1992-05-19 Schacht Etienne Werkwijze voor het bereiden van azobevattende polymeren en het gebruik ervan als geneesmiddelafgiftesystemen.
US5120306A (en) * 1990-03-21 1992-06-09 Gosselin Leon F Direct delivery of anti-inflammatories to the proximal small bowel
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US7122615B1 (en) 1998-09-10 2006-10-17 Rutgers, The State University Of New Jersey Polyanhydrides with therapeutically useful degradation products
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US6486214B1 (en) * 1997-09-10 2002-11-26 Rutgers, The State University Of New Jersey Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
DE19813613A1 (de) 1998-03-27 1999-09-30 Jochen Kerres Modifiziertes Polymer und modifizierte Polymermembran
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
WO2002009769A2 (en) * 2000-07-27 2002-02-07 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
AU2001285311B2 (en) 2000-08-29 2005-09-15 Biocon, Ltd Immunoregulatory compounds, derivatives thereof and their use
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20040096476A1 (en) * 2002-07-17 2004-05-20 Uhrich Kathryn E. Therapeutic devices for patterned cell growth
EP1720536B1 (en) 2004-02-06 2012-04-25 PHARMATEL (R&D) PTY LIMITED as Trustee for the PHARMATEL (R & D) TRUST Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
JP5009152B2 (ja) * 2004-05-28 2012-08-22 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線誘発性腸炎の予防、処置、および回復
ES2565848T3 (es) 2004-07-07 2016-04-07 Biocon Limited Síntesis de compuestos inmunorreguladores unidos por grupos azoicos
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
EP2586427A3 (en) * 2005-08-24 2013-05-29 Salix Pharmaceuticals, Inc. Balsalazide formulations and manufacture thereof
BRPI0622008A2 (pt) * 2006-09-13 2011-12-20 Procter & Gamble métodos de tratamento para colite ulcerativa
WO2008033125A1 (en) * 2006-09-13 2008-03-20 The Procter & Gamble Company Methods of treatment for ulcerative colitis using aminosalicylate
EP2102144A4 (en) 2006-09-13 2011-03-23 Univ Rutgers ACTIVE SUBSTANCES AND THEIR OLIGOMERS AND POLYMERS
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US8497256B2 (en) 2010-04-26 2013-07-30 Salix Pharmaceuticals, Ltd Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
US8741317B2 (en) 2010-08-19 2014-06-03 Rutgers, The State University Of New Jersey Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
US9144579B2 (en) 2012-08-17 2015-09-29 Rutgers, The State University Of New Jersey Polyesters and methods of use thereof
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair
WO2014194055A1 (en) 2013-05-29 2014-12-04 Rutgers, The State University Of New Jersey Antioxidant-based poly(anhydride-esters)
US10023521B2 (en) 2014-06-13 2018-07-17 Rutgers, The State University Of New Jersey Process and intermediates for preparing poly(anhydride-esters)
JP6930918B6 (ja) 2015-04-10 2021-12-15 ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー コウジ酸ポリマー

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862312A (en) * 1968-01-08 1975-01-21 Ici Ltd Compositions comprising a resinate of dl- or l-tetramisole, and treatment therewith
US3920855A (en) * 1973-11-30 1975-11-18 Dynapol Corp Food containing non-toxic food coloring compositions and a process therefor
US4096134A (en) * 1975-12-08 1978-06-20 Dynapol Ethylsulfonate-alkylamine copolymers as colorant backbones

Also Published As

Publication number Publication date
DE2966737D1 (en) 1984-04-05
FI793991A (fi) 1980-06-21
EP0013000B1 (en) 1984-02-29
IL58969A (en) 1983-05-15
MC1302A1 (fr) 1980-10-03
EP0013000A2 (en) 1980-07-09
ES487081A0 (es) 1980-12-16
PT70615A (en) 1980-01-01
IL58969A0 (en) 1980-03-31
AU535100B2 (en) 1984-03-01
AT366068B (de) 1982-03-10
ES8101630A1 (es) 1980-12-16
AU5399579A (en) 1980-07-10
EP0013000A3 (en) 1981-01-21
DK541879A (da) 1980-06-21
IT1162426B (it) 1987-04-01
GR68718B (it) 1982-02-04
NO794171L (no) 1980-06-23
CA1130281A (en) 1982-08-24
ATA802479A (de) 1981-07-15
NZ192458A (en) 1984-07-06
US4298595A (en) 1981-11-03

Similar Documents

Publication Publication Date Title
IT7951122A0 (it) Preparato farmaceutico contenente un agente polimerico per rilasciare acido 5-amminosalicilico e suoi sali nel tratto gastrointestinale,eprocedimento di preparazione
AR211853A1 (es) Procedimiento para la preparacion de las nuevas bis-(dihidroxipropi-amidas)de acido 5-hidroxipropionilamino-2,4,6-triyodoisoftalico facilmente solubles en agua
IE781163L (en) Sustained release of veterinary medicaments
NL191150C (nl) N-(L-leucyl) doxorubicine en zuur-additiezouten daarvan, werkwijze ter bereiding en farmaceutische preparaat.
DE2960292D1 (en) 17-beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes, their pharmaceutical use and processes for their preparation
ZA796881B (en) Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
PT68447A (en) 2-bromoergosine and its acid addition salts a process for the preparation thereof and their use in medicines
NL192741B (nl) Oxazafosforin-4-thioalkaanzuurverbindingen en farmaceutisch preparaat met antineoplastische eigenschappen.
TR20212A (tr) Stabilize azulmik asidler,imallerine mahsus usuller ve kullanilmalari
DE2962430D1 (en) 7-methoxy-5-oxo-5h-thiazolo(2,3-b)quinazolin-2-carboxylic acid and its pharmaceutically acceptable salts, process for their preparation and medicines containing them
NZ184722A (en) Pharmaceutical compositions with controlled release of active agent in the intestinal tract
CY1439A (en) New 5(6)-(2-amino-5-thiazoloyl)-benzimidazole-2-carbamic acid esters and salts thereof,their preparation and use and pharmaceutical formulations containing them
GB2027028B (en) Preparing o-(2,6-dichloroanilino)phenylacetic acid
AU4610479A (en) Anthranilic acid derivatives as pharmaceutical cpds
IL38147A (en) Amidothionophosphonic acid esters,their preparation and their use as herbicides,insecticides,acaricides and nematocides
ZA803466B (en) (3 - alkylamino - 2 - hydroxypropoxy) - furan - 2 - carboxxlic acid anilides and physiologically tolerated acid addition salts thereof, processes for their preparation, and medicaments containing them
IL57778A (en) 2-cyclopropyl-pyrimidin-4-ylthionophosphonic acid esters,their preparation and their use as insecticides and acaricides
IL55895A (en) 2-(2,2-dihalovinyl)-3-methylcyclopropane-carboxylic acid 3-phenoxy- -vinylbenzyl esters,their production and their use in combating insects and acarids
DE2963782D1 (en) Benzimidazolyl-2-carbamic acid esters, medicaments based thereon and process for their preparation
IL57218A (en) 9-deoxy-daunorubicin,9-deoxydoxorubicin,their acid addition salts,preparation thereof and pharmaceutical compositions comprising them
IL50010A0 (en) Novel thionobenzenephosphonic acid o,o-diesters,their preparation and their use as insecticides and acaricides
IL58331A0 (en) Substituted bromostyrl-cyclopropanecarboxylic acid phenoxybenzyl esters, their preparation and their use as insecticides and acaricides
IL51720A0 (en) A novel substituted propionic acid and its salts their preparation and pharmaceutical compositions containing them
GR59322B (en) Process for preparing o-(2,6-dichloroanilino)phenylacetic acid and salts thereof
IL42383A0 (en) New thiolphosphoric acid esters,their preparation and use for combatting pests